Alphaeon announced that Murthy Simhambhatla, PhD, has been appointed CEO and President by the Alphaeon board of directors. Dr. Simhambatla replaces Robert E. Grant who was recently appointed as vice chairman of the Alphaeon board of directors, according to a company news release.
Dr. Simhambhatla joins Alphaeon from Strathspey Crown where he has served as Senior Partner. Prior to joining Strathspey Crown, he was Senior Vice President at Abbott Laboratories and President of Abbott Medical Optics (AMO). Prior to AMO, he led Abbott's Ibis Biosciences business focused on infectious disease diagnostics. He joined Abbott through the acquisition of Guidant's vascular business in 2006, where he was Vice President and General Manager for drug eluting stents. Dr. Simhambhatla holds a bachelor's degree in chemical engineering from Anna University in India and master's and doctorate degrees in polymer engineering from the University of Akron.
"I am honored to join Alphaeon at this exciting time. I believe that the company is uniquely positioned to disrupt lifestyle healthcare through innovative products and its social commerce engine, ShoutMD. I look forward to joining the Alphaeon employees and physician partners around the world as we work together to advance the Company to new heights," Dr. Simhambhatla said in the news release.
“I am very pleased to turn over the executive leadership of the company to such an exceptional and seasoned business leader," Alphaeon Founder and Vice Chairman of the Board Robert E. Grant said in the news release. "Murthy has played an integral role at Strathspey Crown and we wish him great success in this new endeavor at Alphaeon. As announced in late May, my transition had been planned for some time and I look forward to enjoying my new role as Vice Chairman of the Alphaeon Board of Directors in addition to my ongoing responsibilities as Chairman of Strathspey Crown.”